AbbVie, Bristol-Myers sales and marketing update

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in an early benefit assessment that added benefit of Empliciti elotuzumab from Bristol-Myers Squibb and AbbVie in combinatio...